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In-hospital outcomes following staged percutaneous coronary intervention
Staged PCI in
the same
hospitalization
(n184)
Staged PCI at
a separate
hospitalization
(n98) P value
Major adverse cardiac events 6 (3.3%) 1 (1.0%) 0.43
Death 5 (2.7%) 0 (0%) 0.17
Urgent coronary artery
bypass graft
1 (0.5%) 1 (1.0%) 1.00
Procedure-related acute renal
failure
7 (3.8%) 1 (1.0%) 0.27
Vascular complications 6 (3.3%) 3 (3.1%) 1.00
Major bleeding 3 (1.6%) 2 (2.0%) 1.00
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Role Of Coronary Artery Calcium Score In Patients With Stable Angina Pectoris
Underwent Multivessel Percutaneous Coronary Intervention
Jiangli Han,1 Fangfang Wang,1 Rong He,1 Xiangzhu Zeng,2 Fuchun Zhang,1
Lijun Guo,1 Wei Gao1
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Objectives: This study sought to identify whether coronary artery calcium score (CCS)
is associated with procedure complexity, procedure-related complications and long-term
clinical outcomes in patients with stable angina pectoris (SAP) underwent multivessel
percutaneous coronary intervention (PCI).
Methods: 145 SAP patients (male/female, 103/42; age, 6510 years) who underwent
first multivessel PCI following multi-detector computed tomography (MDCT) were
enrolled. We standardized MDCT results into 3 CCS categories (0 to 100, 101 to 400,
and 400) according to recent guidelines. Complex PCI was defined as use of high
pressure balloon, kissing balloon and/or rotablator. Procedure-related complications
included target artery occlusion, dissection, perforation, no/slow flow and emergency
coronary artery bypass grafting. Main adverse cardiac events (MACE) were defined as a
combined end point of death, non-fatal myocardial infarction, target lesion revascular-
ization and rehospitalization for cardiac ischemic events.
Results: As compared with the patients with CCS 100 (n39), those patients with
CCS 101 to 400 (n41) and CCS400 (n65) had significantly higher PCI procedure
complexity (20.5% vs 46.3% vs 38.5, p  0.040). And patients with CCS400 (n65)
had a higher rate of procedure-related complications than patients with CCS184400
(n80) (26.2% vs 6.3%, p 0.001). Three patients (0.02%) were missed during a median
of 21 months’ (1 	 69 months) follow-up. Kaplan-Meier survival analysis showed that
patients with CCS 0 to 100, 101 to 400 and 400 had similar cumulative non-events
survival rates (89.5% vs 82.4% vs 75.0%, p  0.342). However, it showed significant
different cumulative non-events survival rates in female subgroup (100% vs 83.3% vs
58.8%, Log rank 6.005, p  0.049).
Conclusions: Preprocedural CCS assessment by MDCT indicates complexity of PCI
and procedure-related complications in patients with SAP underwent multivessel PCI.
CCS is more relevant with MACE in female patients.
CRT-57
Hybrid Coronary Revascularization (hcr) In Patients With Multi-vessel Coronary
Disease (mvd): Mid-term Results
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Objective: Hybrid Coronary Revascularization, meaning Left Mammary Artery on Left
Anterior Descending (MIDCAB) combined with non-LAD PCI stenting, is considered
as a viable alternative to conventional CABG through sternotomy or to multi-vessel PCI,
in order to perform a functionally complete revascularization. We report our results and
mid-term outcomes of this therapeutic strategy.
Methods: Since January 2009 up to October 2012, 70 consecutive patients underwent
hybrid revascularization after Heart Team evaluation. Coronary risk was assessed by
SYNTAX score, and patients were partitioned in tertiles according to the score categories
(22 low risk, 22 and 33 intermediate risk, 33 high risk). Pre-operative risk
assessment was upgraded to EuroSCORE II for all patients. Long-term outcomes, major
adverse cardiac and cerebrovascular events (MACCE) rate and repeated target vessels
revascularization (TVR) rate were evaluated by Kaplan-Meier curve and log-rank test.
Results: Mean age was 66.3  12.0 years and 83.8% of patients were males. Mean
SYNTAX score was 28,22  7 (mean SYNTAX score in patients with Left main
involved 33,5 4,5). Mean EuroSCORE II was 4,05 1,83. PCI was performed in all
patients (n70), in 52 pts (75,2%) before MIDCAB and in 24,8% of cases after surgery
(interval 2,2  1,3 months). In 12 patients (18,6%) Left Main was involved and
MIDCAB was performed prior to PCI. No intra-operative or in-hospital deaths were
reported. At follow-up one cardiac death for acute inferior myocardial infarction occurred.
Two patients with Left Main needed a repeated non-LAD revascularization: one case for
an acute myocardial infarction and the other due to recurrent angina with in-stent
restenosis at angiography. At 25  13 months follow-up the overall population freedom
from MACCEs rate was 82,6% (CI: 79,5% to 85,7%) and the freedom from TVRs rate
was 86,1% (CI: 82,9% to 89,3%). Despite the rate of MACCE and TVR was higher in
patients with intermediate and high coronary risk than in patients with SYNTAX score 
22, however such difference was not statistically significant (p  0,05).
Conclusions: Hybrid Coronary Revascularization is a viable option to perform a
minimally invasive functionally complete revascularization in high risk patient that can’t
undergo conventional revascularization. However this strategy has better results when
performed on patients with a SYNTAX score 22. In our experience patients with Left
Main HCR had a good outcome at the end of revascularization, although being burdened
by an high TVR rate.
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Hybrid Coronary Revascularization Combining Off-pump Left Internal Mammary
Grafting And Percutaneous Coronary Intervention
Leif Thuesen, Ivy I Modrau, Per Hostrup Nielsen, Bøtker E Hans,
Evald H Christiansen, Lars R Krusell, Anne K Kaltoft, Michael Maeng,
Christian J Terkelsen, Steen D Kristensen, Jens F Lassen
Aarhus University Hospital, Aarhus N, Denmark
Aims: To assess procedural feasibility and early safety of hybrid coronary revasculariza-
tion, combining off-pump left internal mammary artery grafting to the left descendent
coronary artery (LAD) through an inferior J-hemisternotomy (JOPCAB) and percuta-
neous coronary intervention (PCI) of non-LAD lesions.
Methods and Results: A total of 100 consecutive patients with multivessel coronary
artery disease involving LAD were included in this prospective registry. JOPCAB was
performed prior to PCI in 89 (89%) patients, and PCI was scheduled prior to surgery in
11 (11%) patients with total occlusion of a non-LAD artery. Two of these patients were
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treated by CABG, as revascularization by PCI failed. We chose to re-operate one patient
with LIMA graft thrombosis by conventional CABG, as the LAD had shown diffuse
arteriosclerotic disease at JOPCAB. Thus, the procedural success rate was 97%. One
month after completed hybrid intervention, we observed no deaths. There was one stroke
on the fourth postoperative day and two procedure-related, but no spontaneous myocar-
dial infarctions.
Conclusion: Our prospective registry documented excellent procedural feasibility and
one-month safety of coronary hybrid revascularization combining JOPCAB with PCI.
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IVUS Guided PCI: Taxus Liberte Post Approval Study
Steven K Rowe
Lester E. Cox Medical Centers, Springfield, MO
Background: Intravascular ultrasound (IVUS) has been used to quantitate coronary
artery disease burden, understand lesion morphology and optimize PCI. Numerous trials
have investigated the impact of IVUS on outcomes of coronary intervention.
Methods: Using 3615 patients from TAXUS Libertç post approval study (December 29,
2009 -March 16, 2011) demographic features, lesion, and procedural characteristics with
and without IVUS guided PCI were evaluated.
Results: IVUS was utilized in 308/3615 patients (8.5%), 8.8% of lesions and 8.5% of
vessels. Patients undergoing IVUS guided PCI more often presented with stable angina
(41.9% versus 29.5% P0.001), de novo lesions (92.9% versus 95.8% P0.017), a history
of multi vessel disease (42.5% versus 34.4% P0.004 ), vessels greater than 3.5mm (17.6%
versus 9.3% P0.001), long lesions greater than 28mm (16.7% versus 12.5% P 0.011),
LAD (46.5% versus 37.0% P0.001). There was no increased IVUS use in patients with
in-stent restenosis, ostial or left main lesions. IVUS was used less frequently in patients
with STEMI (2.6% versus 10.7% P0.001), total occlusion (2.3% versus 11.8%
P0.001), vessels 2.25mm-2.5mm in diameter (15.6% versus 26.8% P0.001), or
patients with thrombus (4.5% versus 9.7% P0.001). Non Q-Wave MI (ARC Defini-
tion) was higher in the IVUS group (5.5 versus 1.9 P0.001).
Conclusions: In this real world registry, IVUS use was more frequent in de novo lesions
with stable angina, large vessels, long lesions, LAD, in the absence of thrombus and
pre-deployment intervention. All cause mortality or myocardial infarction was higher in
the IVUS group, suggesting a sicker population. IVUS appeared underutilized in left
main, ostial, restenosis lesions or small vessels. Further study is needed to define
appropriate use and indication for IVUS in PCI.
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Drug Eluting Stents versus Bare Metal Stents in Non-Insulin Dependent Diabetic
Patients with Large Coronary Arteries
Ahmed Shawky, Sherif Elzahwy
Ain shams university, Cairo, Egypt
Background: It is well known that the risk of restenosis and other adverse cardiac events
with bare metal stents (BMS) is increased with smaller stent diameters especially in
diabetic patients. Drug eluting stents (DES) have a particular benefit in small vessel
disease that been repeatedly shown in several studies; however, whether this benefit occurs
in diabetic patients with stenoses in large coronary arteries, is still not clear.
Objective: To evaluate the 6 months angiographic & clinical outcome of non- insulin
dependent diabetic patients with large coronary vessels undergoing PCI using DES versus
BMS. The objective was to evaluate the 6 months angiographic & clinical outcome of
non- insulin dependent diabetic patients with large coronary vessels undergoing PCI using
DES versus BMS.
Methods: 6 months angiographic follow up & clinical follow-up for the occurrence of
major clinical events were recorded, including death, myocardial infarction (MI), unstable
angina, cerebrovascular accidents and target lesion revascularization (TLR) were per-
formed for a 60 consecutive non- insulin dependent diabetic patients with stenoses in large
coronary arteries, requiring PCI using stents of 3.0 mm or more in diameter . The patients
were divided into 2 groups; Group I : 30 patients who underwent successful PCI using
second generation DES & Group II : 30 patients who underwent successful PCI using
BMS.
Results: Even though there were no statistically significant difference between both
groups in the occurrence of cardiovascular events (death, MI, unstable angina, cerebro-
vascular accidents)there was a significantly lower incidence of angiographic restenosis and
TLR in the DES treated group compared to BMS treated group (2.2% vs. 9.3% P
0.02). There was also a similar incidence of denovo lesions in both groups (6.7% in each
group).
Conclusions: In non- insulin dependent diabetic patients with large coronary arteries,
Second generation DES demonstrated significantly lower 6 months restenosis rate &
TLR compared to BMS, while there was no significant differences in rates of cardiovas-
cular events during 6 months follow up between both of them.
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Gender Differences in Long Term Outcomes of Coronary Patients Treated with Drug
Eluting Stents at a Tertiary Medical Center
Nicolas W Shammas, Gail A Shammas, Michael Jerin
Midwest cardiovascular Research Foundation, Davenport, IA
Background: Limited data exist on contemporary gender-related differences in long-
term outcomes of coronary patients receiving drug eluting stents. In this study we evaluate
men (M) and women (W) differences for 2-year target lesion failure (TLF) in an
unselected consecutive series of patients treated with the everolimus- (EES) and
paclitaxel-eluting (PES) stents at a tertiary medical center.
Methods: Data on 347 consecutive patients (M 220, W 125) stented with the EES and
PES were retrospectively analyzed. The primary endpoint of the study was to compare
gender related outcomes in TLF defined as the combined endpoint of cardiac death, non
fatal myocardial infarction and target lesion revascularization (TLR). Secondary endpoints
included TLR, target vessel failure (TVF), target vessel revascularization (TVR), acute
stent thrombosis (ST) as defined by the academic research consortium (ARC) and cardiac
death. The cine angiograms of the first consecutive 162 patients (M 105, W 57) were
independently reviewed by a cardiologist blinded to clinical outcome and SYNTAX
scoring was performed. Follow-up was achieved using medical records and/or phone calls
and was censored at 2 years. Descriptive analysis was performed on all variables. Univariate
analysis compared the men and women cohorts. Propensity matched analysis was
performed to account for differences between M and W.
Results: M had more prior PCI and restenotic lesions and a higher prevalence of
smoking. They also had longer length of disease and received more stents than W. W
were older and had higher prevalence of prior stroke. Angiographic complexity was
statistically similar between the 2 groups as judged by SYNTAX scoring (M 20.8 13.8,
W 19.7 13.9, p 0.650). At 2 years follow up, TLF was 27.4% and 24.8% (p0.614)
with no statistical difference between TLR (23.3% vs. 21.6%), cardiac death (2.8% vs.
3.2%) and definite and probable stent thrombosis (2.3% vs. 0.0%). Propensity matched
analysis showed a statistically similar TLF and TVF between M and W (20.3  16 vs.
27.5  22 (p0.363) and 28.8  23 vs. 35.5  29 (p0.400) respectively).
Conclusion: In this cohort of patients receiving EES and PES, men and women had
similar outcomes at 2- year follow-up consistent with recent reports in the current era of
PCI.
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Age Differences in Long-Term Outcomes of Coronary Patients Treated with Drug
Eluting Stents at a Tertiary Medical Center
Nicolas W Shammas, Gail A Shammas, Michael Jerin
Midwest cardiovascular Research Foundation, Davenport, IA
Background: Limited data exist on contemporary age-related differences in long-term
outcomes of coronary patients receiving drug eluting stents. In this study we evaluate
differences in outcomes in young ( 65 years) (Y) and elderly ( 65 years) (E) patients
for target lesion failure (TLF) at 2-year follow-up in an unselected consecutive series of
patients treated with the everolimus- (EES) and paclitaxel-eluting (PES) stents at a
tertiary medical center.
Methods: Data on 347 consecutive patients (Y 149; E 198) stented with the EES and
PES were retrospectively analyzed. The primary endpoint of the study was to compare age
related outcomes in TLF defined as the combined endpoint of cardiac death, non fatal
myocardial infarction and target lesion revascularization (TLR). Secondary endpoints
included TLR, target vessel failure (TVF), target vessel revascularization (TVR), acute
stent thrombosis (ST) as defined by the academic research consortium (ARC) and cardiac
death. Analysis was done with number of patients as the denominator. Cine angiograms
of the first consecutive 163 patients (Y 64; E 99) were independently reviewed by a
cardiologist blinded to clinical outcome and SYNTAX scoring was performed. Follow-up
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